Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-12
1995-12-26
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544267, C07D47306, A61K 3152
Patent
active
054788315
ABSTRACT:
R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its preparation, and pharmaceuticals which contain this compound and which are suitable, in particular, for the prophylaxis and treatment of cerebral vascular disorders.
REFERENCES:
patent: 4108995 (1978-08-01), Mohler et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4576947 (1986-03-01), Hinze et al.
Davis, P. J., et al., Mircobial Models of Mammalian Metabolism: Stereospecificity of Ketone Reduction with Pentoxifylline, Xenobiotica, vol. 15, No. 12, 1985, pp. 1001-1010.
Merete Ruud-Christensen et al., Separation of (R)-And (S)-proxyphylline As Diastereoisomeric Camphantes By Reversed-phase Liquid Chromotography, Journal of Chromatography 303 (1984) pp. 433-435.
Davis, P. J., et al., Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidation of Pentoxifyline, Applied and Environmental Microbiology, Aug. 1984, pp. 327-331, vol. 48, No. 2.
Merete Ruud-Christensen et al., Synthesis of (R)-and (S)-proxyphylline, 1984 Acta Chemica Scandinavica.
M. Christen et al., J. Chem Soc., Chem Comm. 264-44 (1988).
ATCC Catalogue of Yeasts at 71 (18th Ed., 1990).
Furrer Harald
Gebert Ulrich
Rudolphi Karl
Hoechst Aktiengesellschaft
Rizzo Nicholas
LandOfFree
R-(-)1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with R-(-)1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and R-(-)1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1369365